Kidney failure is a global epidemic, with around 850 million people suffering from it. A team of researchers from multicenter institutes was successful in inhibiting a protein (interleukin-11) that plays a major role in organ damage using neutralizing antibodies in pre-clinical studies in mice. The resulting therapy aids regeneration of the injured kidneys, restoring renal function, besides being safe for long-term use. The study revealed significant improvement in all mice, no matter the degree of damage to the kidney.
The neutralizing antibodies led the tubule cells to regenerate the kidney , reversing the damage. The therapy can potentially treat people at risk of acute kidney disease to prevent it, treat people with the condition, and reduce kidney damage, and can be used for patients with established chronic disease to reverse it. Do you think the use of neutralizing antibodies…
